187 related articles for article (PubMed ID: 11022795)
1. Clinical use of cefuroxime in paediatric community-acquired pneumonia.
Olivier C
Paediatr Drugs; 2000; 2(5):331-43. PubMed ID: 11022795
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
[TBL] [Abstract][Full Text] [Related]
3. Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.
Van den Brande P; Vondra V; Vogel F; Schlaeffer F; Staley H; Holmes C
Chest; 1997 Aug; 112(2):406-15. PubMed ID: 9266876
[TBL] [Abstract][Full Text] [Related]
4. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Scott LJ; Ormrod D; Goa KL
Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
[TBL] [Abstract][Full Text] [Related]
6. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.
Rittenhouse BE; Stinnett AA; Dulisse B; Henke CJ; Potter L; Parasuraman B; Martens LL; Williams RR; Kojak C
Am J Manag Care; 2000 Mar; 6(3):381-9. PubMed ID: 10977438
[TBL] [Abstract][Full Text] [Related]
9. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Oh HM; Ng AW; Lee SK
Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
[TBL] [Abstract][Full Text] [Related]
10. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
11. Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy.
Shalit I; Dagan R; Engelhard D; Ephros M; Cuningham K
Isr J Med Sci; 1994 Sep; 30(9):684-9. PubMed ID: 8088980
[TBL] [Abstract][Full Text] [Related]
12. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
See S
J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
[No Abstract] [Full Text] [Related]
13. [Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility].
Cluzel R; Portier H; Modaï J
Pathol Biol (Paris); 1996 Mar; 44(3):217-23. PubMed ID: 8761613
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study.
Kuzman I; Daković-Rode O; Oremus M; Banaszak AM
J Chemother; 2005 Dec; 17(6):636-42. PubMed ID: 16433194
[TBL] [Abstract][Full Text] [Related]
15. [Program of empirical antibacterial therapy of community-acquired pneumonia].
Suvorova MP; Iakovlev SV; Shakhova TV; Dvoretskiĭ LI
Antibiot Khimioter; 1998; 43(7):31-5. PubMed ID: 9727165
[TBL] [Abstract][Full Text] [Related]
16. [Parenteral cephalosporins for the treatment of lower respiratory tract infections].
Vogel F
Infection; 1993; 21 Suppl 1():S28-34. PubMed ID: 8314290
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin in the treatment of community acquired pneumonia.
File TM
Can Respir J; 1999; 6 Suppl A():35A-9A. PubMed ID: 10202232
[TBL] [Abstract][Full Text] [Related]
18. Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime.
Rovira E; Martínez-Moragón E; Belda A; Gonzalvo F; Ripollés F; Pascual JM
Respiration; 1999; 66(5):413-8. PubMed ID: 10516537
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E
Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471
[TBL] [Abstract][Full Text] [Related]
20. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
